DAMIN CHEN
Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant SAINT PETERSBURG, FL NPI 1801647201
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant FL Amgen Inc. All categories
General Payments — all program years on this page
$818.13
- Category: General Payments
- Program years: PY2024
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $818.13 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $818.13 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $251.31 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $124.95 | 1 |
| SI-BONE, INC. | $123.89 | 1 |
| Acerta Pharma LLC | $122.05 | 1 |
| Novo Nordisk AS | $98.46 | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $97.47 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2024 | $818.13 | 8 |
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086354706 | Bayer Healthcare Pharmaceuticals Inc. | $124.95 | 04/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100638384 | Novo Nordisk Inc | $98.46 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105773968 | AstraZeneca Pharmaceuticals LP | $122.05 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115496295 | Amgen Inc. | $10.39 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115496305 | Amgen Inc. | $120.46 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115496314 | Amgen Inc. | $120.46 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118841183 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $97.47 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1120073966 | SI-BONE, INC. | $123.89 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.